The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

Sonja Baumli(University of Oxford), Graziano Lolli(University of Oxford), E.D. Lowe(University of Oxford), Sonia Troiani(Nerviano Medical Sciences), Luisa Rusconi(Nerviano Medical Sciences), Alex N. Bullock(Genomics (United Kingdom)), J.E. Debreczeni(University of Oxford), Stefan Knapp(Genomics (United Kingdom)), L.N. Johnson(University of Oxford)
The EMBO Journal
June 19, 2008
10.1038/emboj.2008.121
Cited by 353Open Access
Full Text

Abstract

Related Papers

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Philip D. Jeffrey, Alicia A. Russo, Kornélia Polyák et al.|Nature|1995|1.4k
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Geoffrey I. Shapiro|Journal of Clinical Oncology|2006|1k
7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes
Van Trung Nguyen, Tamás Kiss, Annemieke A. Michels et al.|Nature|2001|703
Elongation by RNA polymerase II: the short and long of it
Robert J. Sims, Rimma Belotserkovskaya, Danny Reinberg|Genes & Development|2004|686
The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription
Zhiyuan Yang, Qingwei Zhu, Kunxin Luo et al.|Nature|2001|681